Gladstone Institutional Advisory’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $477K | Sell |
27,866
-41,094
| -60% | -$703K | 0.02% | 508 |
|
|
2025
Q1 | $4.4M | Sell |
68,960
-4,925
| -7% | -$314K | 0.21% | 119 |
|
|
2024
Q4 | $8.98M | Sell |
73,885
-9,415
| -11% | -$1.14M | 0.42% | 50 |
|
|
2024
Q3 | $10.4M | Buy |
83,300
+26,900
| +48% | +$3.36M | 0.51% | 45 |
|
|
2024
Q2 | $8.91M | Buy |
56,400
+40
| +0.1% | +$6.32K | 0.46% | 47 |
|
|
2024
Q1 | $7.3M | Buy |
+56,360
| New | +$7.3M | 0.4% | 58 |
|
|
2021
Q4 | – | Sell |
-2,455
| Closed | -$227K | – | 632 |
|
|
2021
Q3 | $227K | Buy |
+2,455
| New | +$227K | 0.02% | 489 |
|